BLUEWATER BIOSCIENCES
Live / Applied — Non-final action mailed (as of 21 Feb 2026)
What this means for you
Not registered yet, but its 10 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98593612
- Mark type
- Design + words
- Filed
- 10 Jun 2024
- Attorney of record
- Michelle Bolos
Goods and services
- Class 005 — Pharmaceuticals: Synthetic peptide-conjugates and peptide-drugs for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, inflammatory, cardiomyopathies, heart muscle, auto-immune, obesity, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, psychological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- BlueWater Biosciences Inc, La Jolla, CA, US
Prosecution history
- 21 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Feb 2026 — NON-FINAL ACTION E-MAILED
- 21 Feb 2026 — NON-FINAL ACTION WRITTEN
- 25 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 May 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 27 May 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 24 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Feb 2025 — NON-FINAL ACTION E-MAILED
- 24 Feb 2025 — NON-FINAL ACTION WRITTEN
- 12 Jan 2025 — ASSIGNED TO EXAMINER
- 11 Jan 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 11 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Jun 2024 — NEW APPLICATION ENTERED